209 related articles for article (PubMed ID: 19247654)
1. Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia.
Umeda Y; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Saito Y; Tsuchida T; Fujibayashi Y; Okazawa H
Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1121-30. PubMed ID: 19247654
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis.
Umeda Y; Demura Y; Morikawa M; Anzai M; Kadowaki M; Ameshima S; Tsuchida T; Tsujikawa T; Kiyono Y; Okazawa H; Ishizaki T; Ishizuka T
J Nucl Med; 2015 Dec; 56(12):1869-75. PubMed ID: 26359263
[TBL] [Abstract][Full Text] [Related]
3. Novel positron emission tomography/computed tomography of diffuse parenchymal lung disease combining a labeled somatostatin receptor analogue and 2-deoxy-2[18F]fluoro-D-glucose.
Win T; Screaton NJ; Porter J; Endozo R; Wild D; Kayani I; Dickson J; Shortman RI; Reubi JC; Ell PJ; Groves AM
Mol Imaging; 2012 Apr; 11(2):91-8. PubMed ID: 22469237
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis.
Umeda Y; Demura Y; Morikawa M; Ameshima S; Tsuchida T; Fujibayashi Y; Okazawa H; Ishizaki T
Respirology; 2011 May; 16(4):713-20. PubMed ID: 21382131
[TBL] [Abstract][Full Text] [Related]
5. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.
Tian R; Su M; Tian Y; Li F; Li L; Kuang A; Zeng J
Skeletal Radiol; 2009 May; 38(5):451-8. PubMed ID: 19205695
[TBL] [Abstract][Full Text] [Related]
6. Correlation between preoperative
Oishi H; Sakurada A; Notsuda H; Tanaka R; Takanami K; Saito R; Eba S; Noda M; Okada Y
Respir Investig; 2021 Jan; 59(1):106-113. PubMed ID: 33004286
[TBL] [Abstract][Full Text] [Related]
7. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
8. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.
Nishiyama Y; Yamamoto Y; Fukunaga K; Kimura N; Miki A; Sasakawa Y; Wakabayashi H; Satoh K; Ohkawa M
J Nucl Med; 2006 Apr; 47(4):633-8. PubMed ID: 16595497
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
Shum WY; Hsieh TC; Yeh JJ; Chen JH; Su CC; Liang JA; Kao CH
Eur J Radiol; 2012 May; 81(5):1024-8. PubMed ID: 21458941
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
Shimizu K; Okita R; Saisho S; Yukawa T; Maeda A; Nojima Y; Nakata M
Ann Nucl Med; 2015 Dec; 29(10):854-60. PubMed ID: 26254228
[TBL] [Abstract][Full Text] [Related]
12. Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.
Wu A; Zheng H; Kraenzle J; Biller A; Vanover CD; Proctor M; Sherwood L; Steffen M; Ng C; Mollura DJ; Jonsson CB
ILAR J; 2012; 53(1):E9-21. PubMed ID: 23382267
[TBL] [Abstract][Full Text] [Related]
13. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
Conrad GR; Sinha P
Nucl Med Commun; 2003 Nov; 24(11):1129-37. PubMed ID: 14569166
[TBL] [Abstract][Full Text] [Related]
14. The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.
Macdonald K; Searle J; Lyburn I
Clin Radiol; 2011 Mar; 66(3):244-50. PubMed ID: 21295203
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.
Demura Y; Tsuchida T; Ishizaki T; Mizuno S; Totani Y; Ameshima S; Miyamori I; Sasaki M; Yonekura Y
J Nucl Med; 2003 Apr; 44(4):540-8. PubMed ID: 12679397
[TBL] [Abstract][Full Text] [Related]
16. Is
Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
18. [Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
Su MG; Fan QP; Tian Y; Li FL; Yang XC; Li L; Fan CZ; Tian R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):517-20. PubMed ID: 19627018
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors.
Hamada K; Tomita Y; Ueda T; Enomoto K; Kakunaga S; Myoui A; Higuchi I; Yoshikawa H; Hatazawa J
Ann Nucl Med; 2006 Dec; 20(10):671-5. PubMed ID: 17385305
[TBL] [Abstract][Full Text] [Related]
20. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
